Developer docs
API playgroundTry for free, no card

Search company profiles

ATMA CENA

Full company profile

uuid00sj18s

Namestring
ATMA CENA
Legal namestring
AtmaCena Inc.
Websiteurl
atmacena.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

ATMA CENA (legal entity: AtmaCena Inc.) is a Calgary-headquartered, Edmonton-anchored Canadian specialty healthcare company that operates a platform-plus-network model for psychedelic-assisted mental healthcare. It runs two corporate clinics (Edmonton and Calgary) that deliver General Therapy, Psychedelic-Assisted Therapy (PAT) using ketamine, psilocybin, and MDMA via Health Canada's Special Access Programme (SAP), and Repetitive Transcranial Magnetic Stimulation (rTMS), targeting treatment-resistant depression, anxiety, PTSD, addiction, chronic pain, end-of-life distress, and tinnitus. The company is fully licensed under Alberta's Psychedelic Drug Treatment Services (PDTS) framework and holds CPSA accreditation for its Edmonton clinic, with Calgary accreditation in progress.

Adjacent to clinical services, ATMA CENA operates a professional training business delivered via the Kajabi learning platform. The catalog comprises three CE/CME-accredited pathways (Clinical, Prescriber, Integrative) plus add-on modules including PAT Foundations, Applied Clinical Practice, Supervised Learning Lab, and KAT Immersive Experience, with per-course tuition ranging from $800 to $4,200 CAD. Over 1,000 practitioners have been trained since 2021. Trained clinicians can join the CoCare program to deliver PAT within ATMA CENA's national network.

The third revenue engine is a member clinic network that currently comprises 11 partner clinics across Ontario, Quebec, Saskatchewan, and Manitoba, structured with exclusive per-city market positioning. Member clinics pay for protocols, staff training, regulatory guidance, and operational systems under a franchise-like arrangement, while ATMA CENA earns licensing/membership fees and routes patient referrals through its physician and therapist referral programs. The company is privately held, was formed in 2023 as a joint venture between Cena Life and ATMA Journey, employs 11-50 staff, and is actively soliciting investors through a Psychedelic Therapy Investor Program with a stated goal of doubling annual revenue each year for the next three years.

Short descriptiontext

ATMA CENA operates a Canadian specialty mental healthcare platform delivering psychedelic-assisted therapy, rTMS, and general therapy through two corporate clinics in Alberta and an 11-clinic national member network, while running CE/CME-accredited professional training programs and an investor-backed growth program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCalgary, Canada
HQ citystring
Calgary
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychedelic-assisted therapy, transcranial magnetic stimulation, mental health treatment, professional therapy training, clinic network membership
Industry2 codes
PRIMARYEDAAALAD
Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYHLALAIAM
Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
NAICS code3 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Outpatient Mental Health and Substance Abuse Centers62142
  • Educational Support Services61171
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Mental Healthcare / Psychedelic-Assisted Therapy Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Therapy Services
TypeProfessional Services
Description

Direct patient care including psychedelic-assisted therapy (ketamine, psilocybin, MDMA through SAP), rTMS, and general therapy services. Revenue generated from treatment sessions at corporate clinics in Edmonton and Calgary and through member clinic network.

atmacena.com
2Professional Training Programs
TypeProfessional Services
Description

CE-sponsored psychedelic therapy training programs across three pathways (Clinical, Prescriber, Integrative). Revenue from course tuition including PAT Foundations, Applied Clinical Practice, Prescribing & Oversight, Advanced Safety & Support Practices, Supervised Learning Lab, and KAT Immersive Experience.

atmacena.com
3Member Clinic Network
TypeLicensing Royalties
Description

National clinic network membership providing regulatory guidance, staff training, operational systems, and access to qualified therapist referral network. Partner clinics receive exclusive market positioning in their communities.

atmacena.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details6 tiers
1PAT Foundations - Entry-level 14-hour self-paced course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$800 CAD for 14 hours, 14 CE credits. Self-paced online course covering history, science, ethics, and clinical application of psychedelic-assisted therapy.

atmacena.com
2Applied Clinical Practice - 46-hour advanced course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$4,200 CAD for 46 hours, 46 CE credits. Online plus practicum format.

atmacena.com
3Prescribing & Oversight - 40-hour prescriber pathway
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$4,000 CAD for 40 hours, 40 CME credits. Hybrid format for physicians and nurse practitioners.

atmacena.com
4Advanced Safety & Support Practices - 38-hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$3,500 CAD for 38 hours, 38 CE credits. Hybrid format.

atmacena.com
5Supervised Learning Lab - 8-hour small-group live session
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$1,000 CAD for 8 hours, 8 CE credits. Small-group cohort format with 4 weekly live sessions, capped at 8 participants.

atmacena.com
6KAT Immersive Experience - Optional 3-day in-person experiential training
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$2,400 CAD for 3 days. In-person in Calgary only. CE approval pending. Maximum 10 participants per cohort.

atmacena.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 2 records shown
1CoCare
Description

A program enabling clinic owners and practitioners to integrate psychedelic-assisted therapy into their practices with ATMA CENA's clinical protocols, operational systems, and access to a therapist referral network.

atmacena.com
+1 more record
Core offering1 text field

ATMA CENA operates a network of licensed clinics providing psychedelic-assisted therapy (using ketamine, psilocybin, and MDMA through the SAP), repetitive transcranial magnetic stimulation (rTMS), and general therapy services for treatment-resistant mental health conditions. The company complements its clinical practice with three CE/CME-accredited professional training pathways and a CoCare model that lets graduates deliver PAT within ATMA CENA-affiliated clinics, as well as a National Member Clinic Network that franchises ATMA CENA protocols and brand across Canada with one clinic per city.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1,000 practitioners trained since 2021
+2 more records
Product overview1 text field

ATMA CENA operates a platform-plus-network model for psychedelic-assisted mental healthcare. The core offering comprises three main service lines: General Therapy Services, Psychedelic-Assisted Therapy (PAT) using ketamine, and Repetitive Transcranial Magnetic Stimulation (rTMS). PAT serves as the flagship innovative treatment for treatment-resistant conditions. Adjacent to clinical services, ATMA CENA offers professional training through three pathways (Clinical, Prescriber, Integrative) plus optional Supervised Learning Lab and KAT Immersive Experience, all delivered via Kajabi. The CoCare Program allows trained practitioners to practice within ATMA CENA's network. A National Clinic Network Member Program extends the brand nationally through franchised member clinics. Supporting infrastructure includes Physician/NP and Therapist referral programs. The company also maintains an investor relations program for capital raising.

Product and service11 records
1General Therapy Services
CategoryClinical Therapy Services
Description

Traditional therapy services provided by licensed therapists for individuals and families addressing various mental health concerns and life challenges, delivered at ATMA CENA's Edmonton and Calgary corporate clinics.

2Psychedelic-Assisted Therapy (PAT)
CategoryClinical Therapy Services
Description

Innovative mental health treatment combining psychedelic medicine administration (ketamine, psilocybin, and MDMA through SAP) with professional psychological support to achieve therapeutic outcomes for depression, PTSD, anxiety, and addiction, delivered at licensed Alberta corporate clinics.

3Repetitive Transcranial Magnetic Stimulation (rTMS)
CategoryClinical Therapy Services
Description

Non-invasive brain stimulation therapy using magnetic fields to stimulate nerve cells in the brain for treatment of depression and other mental health conditions, characterized by minimal side effects, delivered at ATMA CENA's Edmonton and Calgary clinics.

4Psychedelic Therapy Training — Clinical Pathway
CategoryProfessional Training
Description

Professional training program for licensed therapists, psychologists, counselors, and social workers preparing to deliver psychedelic-assisted therapy directly, including supervised practice pathways and CE credits (anchored by the Applied Clinical Practice 46-hour course at CAD $4,200).

5Psychedelic Therapy Training — Prescriber Pathway
CategoryProfessional Training
Description

Training program for physicians, psychiatrists, and nurse practitioners covering prescribing authority, medical oversight, and clinical protocols for psychedelic-assisted therapy, eligible for CME credits.

6Psychedelic Therapy Training — Integrative Pathway
CategoryProfessional Training
Description

Training pathway for wellness professionals including coaches, addictions counselors, and allied health practitioners entering the field of psychedelic-assisted therapy within collaborative care models.

7PAT Foundations
CategoryProfessional Training
Description

14-hour self-paced online foundational course covering history, science, ethics, and clinical application of psychedelic-assisted therapy, earning 14 CE credits upon completion.

8Supervised Learning Lab
CategoryProfessional Training
Description

Small-group live skills practice session (four weekly two-hour live sessions capped at eight participants) for hands-on training in psychedelic-assisted therapy techniques.

9KAT Immersive Experience
CategoryProfessional Training
Description

Optional 3-day in-person experiential training where practitioners experience the full arc of ketamine-assisted therapy from the client perspective, including intake, preparation, supervised dosing weekend, and integration in groups of up to 10 participants.

10CoCare Program
CategoryClinic Network / Partnership
Description

Program enabling qualified therapists and practitioners to offer psychedelic-assisted therapy in their own practices with ATMA CENA providing clinical protocols, operational systems, and access to the clinic network.

11National Clinic Network Member Program
CategoryClinic Network / Partnership
Description

Franchise-like network partnership allowing clinic owners to integrate psychedelic-assisted therapy services with ATMA CENA providing regulatory guidance, staff training, clinical protocols, and exclusive market positioning per city.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Co-authored position paper on Alberta's Psychedelic Drug Treatment Services framework with MAPS Canada. Reverdi Darda, CEO, co-authored the report providing balanced analysis of provincial regulations. Joint advocacy for safety and access in psychedelic regulation.

2The Rooted Space
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Member clinic partner in Kitchener-Waterloo, Ontario. Integrative wellness clinic offering psychedelic-assisted psychotherapy, traditional psychotherapy, neurofeedback, and holistic wellness services. Empowered by ATMA CENA to offer PAT services.

atmacena.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Member clinic partner in Winnipeg providing psychedelic-assisted therapy services as part of ATMA CENA's national clinic network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Member clinic partner in Saskatoon offering psychedelic-assisted therapy as part of the ATMA CENA national clinic network.

5College of Physicians and Surgeons of Alberta (CPSA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regulatory oversight body that provides accreditation for ATMA CENA's Edmonton clinic and oversees the accreditation process for Calgary clinic. Sets standards for psychedelic-assisted therapy in Alberta under PDTS framework.

atmacena.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Braxia Scientific
TypeDirect peer
Description

Canadian ketamine clinic operator and psychiatric research platform (now part of Numinus). Directly comparable to ATMA CENA on ketamine-assisted therapy delivery and Canadian specialty outpatient mental-health positioning.

TypeEmerging player
Description

Clinical-stage psychedelic therapeutics company developing psilocybin-based treatments for mental health. Comparable to ATMA CENA's psilocybin-assisted therapy segment but at the drug-development phase.

TypeBroad incumbent
Description

Public clinical-stage company developing psilocybin therapy for treatment-resistant depression. Overlaps with ATMA CENA on psilocybin-assisted therapy but operates as a drug-development incumbent rather than a clinic operator.

4MindMed
TypeBroad incumbent
Description

Public psychedelic medicine company developing LSD and MDMA-based therapies. Comparable to ATMA CENA's PAT offering but at the biopharma development stage rather than clinic-delivery stage.

5Field Trip Health
TypeDirect peer
Description

Was a leading Canadian psychedelic therapy clinic operator (ketamine-assisted psychotherapy) with locations across North America before ceasing operations. Served as the prior template for ATMA CENA's clinic-plus-network model in the Canadian market.

TypeEmerging player
Description

Subsidiary of MAPS focused on developing and delivering MDMA-assisted therapy. Strongly comparable to ATMA CENA's MDMA-via-SAP offering and a key advocacy partner shaping psychedelic therapy policy that ATMA CENA is engaging.

TypeEmerging player
Description

Clinical-stage company developing mebufotenin (5-MeO-DMT)-based therapies for treatment-resistant depression. Adjacent to ATMA CENA's psychedelic therapy menu, focused on a different molecule but a similar treatment-resistant mental-health patient population.

TypeDirect peer
Description

Canadian psychedelic therapy company operating clinics and offering ketamine-assisted therapy alongside practitioner training. Numinus is the closest geographic and business-model peer to ATMA CENA, including its acquisition of Braxia Scientific (Canadian ketamine clinics).

9Novamind
TypeDirect peer
Description

Operates specialty mental-health and ketamine-assisted therapy clinics in Canada alongside clinical research sites. Comparable to ATMA CENA in combining outpatient psychedelic therapy delivery with research capabilities.

TypeDirect peer
Description

Focused on psychedelic-assisted therapies for traumatic brain injury and neurological conditions. Comparable niche overlap with ATMA CENA's chronic pain and tinnitus psychedelic treatment indications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ATMA CENA

Mental Healthcare / Psychedelic-Assisted Therapy Servicesatmacena.com

ATMA CENA operates a Canadian specialty mental healthcare platform delivering psychedelic-assisted therapy, rTMS, and general therapy through two corporate clinics in Alberta and an 11-clinic national member network, while running CE/CME-accredited professional training programs and an investor-backed growth program.

What ATMA CENA does

ATMA CENA (legal entity: AtmaCena Inc.) is a Calgary-headquartered, Edmonton-anchored Canadian specialty healthcare company that operates a platform-plus-network model for psychedelic-assisted mental healthcare. It runs two corporate clinics (Edmonton and Calgary) that deliver General Therapy, Psychedelic-Assisted Therapy (PAT) using ketamine, psilocybin, and MDMA via Health Canada's Special Access Programme (SAP), and Repetitive Transcranial Magnetic Stimulation (rTMS), targeting treatment-resistant depression, anxiety, PTSD, addiction, chronic pain, end-of-life distress, and tinnitus. The company is fully licensed under Alberta's Psychedelic Drug Treatment Services (PDTS) framework and holds CPSA accreditation for its Edmonton clinic, with Calgary accreditation in progress.

Adjacent to clinical services, ATMA CENA operates a professional training business delivered via the Kajabi learning platform. The catalog comprises three CE/CME-accredited pathways (Clinical, Prescriber, Integrative) plus add-on modules including PAT Foundations, Applied Clinical Practice, Supervised Learning Lab, and KAT Immersive Experience, with per-course tuition ranging from $800 to $4,200 CAD. Over 1,000 practitioners have been trained since 2021. Trained clinicians can join the CoCare program to deliver PAT within ATMA CENA's national network.

The third revenue engine is a member clinic network that currently comprises 11 partner clinics across Ontario, Quebec, Saskatchewan, and Manitoba, structured with exclusive per-city market positioning. Member clinics pay for protocols, staff training, regulatory guidance, and operational systems under a franchise-like arrangement, while ATMA CENA earns licensing/membership fees and routes patient referrals through its physician and therapist referral programs. The company is privately held, was formed in 2023 as a joint venture between Cena Life and ATMA Journey, employs 11-50 staff, and is actively soliciting investors through a Psychedelic Therapy Investor Program with a stated goal of doubling annual revenue each year for the next three years.

ATMA CENA firmographics

Firmographics
Name
ATMA CENA
Legal name
AtmaCena Inc.
Website
https://atmacena.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
ATMA CENA operates a Canadian specialty mental healthcare platform delivering psychedelic-assisted therapy, rTMS, and general therapy through two corporate clinics in Alberta and an 11-clinic national member network, while running CE/CME-accredited professional training programs and an investor-backed growth program.
Ownership category
akta.pro rank

ATMA CENA industry classification

Industry
Product category
Mental Healthcare / Psychedelic-Assisted Therapy Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142), Educational Support Services (61171)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYEDAAALAD
Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE)
Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)
SECONDARYHLALAIAM
Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

  • Psychedelic-assisted therapy
  • Transcranial magnetic stimulation
  • Mental health treatment
  • Professional therapy training
  • Clinic network membership

Where ATMA CENA is headquartered

Location

Headquarters

HQ city
Calgary
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

ATMA CENA business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Clinical Therapy Services: Direct patient care including psychedelic-assisted therapy (ketamine, psilocybin, MDMA through SAP), rTMS, and general therapy services. Revenue generated from treatment sessions at corporate clinics in Edmonton and Calgary and through member clinic network.
  2. Professional Training Programs: CE-sponsored psychedelic therapy training programs across three pathways (Clinical, Prescriber, Integrative). Revenue from course tuition including PAT Foundations, Applied Clinical Practice, Prescribing & Oversight, Advanced Safety & Support Practices, Supervised Learning Lab, and KAT Immersive Experience.
  3. Member Clinic Network: National clinic network membership providing regulatory guidance, staff training, operational systems, and access to qualified therapist referral network. Partner clinics receive exclusive market positioning in their communities.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goPAT Foundations - Entry-level 14-hour self-paced course
One time/ perpetual licensePay-as-you-goApplied Clinical Practice - 46-hour advanced course
One time/ perpetual licensePay-as-you-goPrescribing & Oversight - 40-hour prescriber pathway
One time/ perpetual licensePay-as-you-goAdvanced Safety & Support Practices - 38-hour course
One time/ perpetual licensePay-as-you-goSupervised Learning Lab - 8-hour small-group live session
One time/ perpetual licensePay-as-you-goKAT Immersive Experience - Optional 3-day in-person experiential training

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

ATMA CENA product offering

Product offering

Core offering

ATMA CENA operates a network of licensed clinics providing psychedelic-assisted therapy (using ketamine, psilocybin, and MDMA through the SAP), repetitive transcranial magnetic stimulation (rTMS), and general therapy services for treatment-resistant mental health conditions. The company complements its clinical practice with three CE/CME-accredited professional training pathways and a CoCare model that lets graduates deliver PAT within ATMA CENA-affiliated clinics, as well as a National Member Clinic Network that franchises ATMA CENA protocols and brand across Canada with one clinic per city.

Product overview

ATMA CENA operates a platform-plus-network model for psychedelic-assisted mental healthcare. The core offering comprises three main service lines: General Therapy Services, Psychedelic-Assisted Therapy (PAT) using ketamine, and Repetitive Transcranial Magnetic Stimulation (rTMS). PAT serves as the flagship innovative treatment for treatment-resistant conditions. Adjacent to clinical services, ATMA CENA offers professional training through three pathways (Clinical, Prescriber, Integrative) plus optional Supervised Learning Lab and KAT Immersive Experience, all delivered via Kajabi. The CoCare Program allows trained practitioners to practice within ATMA CENA's network. A National Clinic Network Member Program extends the brand nationally through franchised member clinics. Supporting infrastructure includes Physician/NP and Therapist referral programs. The company also maintains an investor relations program for capital raising.

Differentiator

Problem solved

Functional benefit

Brands

  • CoCare: A program enabling clinic owners and practitioners to integrate psychedelic-assisted therapy into their practices with ATMA CENA's clinical protocols, operational systems, and access to a therapist referral network.
  • Psychedelic Therapy Training

Products and services

  • General Therapy Services Traditional therapy services provided by licensed therapists for individuals and families addressing various mental health concerns and life challenges, delivered at ATMA CENA's Edmonton and Calgary corporate clinics.
  • Psychedelic-Assisted Therapy (PAT) Innovative mental health treatment combining psychedelic medicine administration (ketamine, psilocybin, and MDMA through SAP) with professional psychological support to achieve therapeutic outcomes for depression, PTSD, anxiety, and addiction, delivered at licensed Alberta corporate clinics.
  • Repetitive Transcranial Magnetic Stimulation (rTMS) Non-invasive brain stimulation therapy using magnetic fields to stimulate nerve cells in the brain for treatment of depression and other mental health conditions, characterized by minimal side effects, delivered at ATMA CENA's Edmonton and Calgary clinics.
  • Psychedelic Therapy Training — Clinical Pathway Professional training program for licensed therapists, psychologists, counselors, and social workers preparing to deliver psychedelic-assisted therapy directly, including supervised practice pathways and CE credits (anchored by the Applied Clinical Practice 46-hour course at CAD $4,200).
  • Psychedelic Therapy Training — Prescriber Pathway Training program for physicians, psychiatrists, and nurse practitioners covering prescribing authority, medical oversight, and clinical protocols for psychedelic-assisted therapy, eligible for CME credits.
  • Psychedelic Therapy Training — Integrative Pathway Training pathway for wellness professionals including coaches, addictions counselors, and allied health practitioners entering the field of psychedelic-assisted therapy within collaborative care models.
  • PAT Foundations 14-hour self-paced online foundational course covering history, science, ethics, and clinical application of psychedelic-assisted therapy, earning 14 CE credits upon completion.
  • Supervised Learning Lab Small-group live skills practice session (four weekly two-hour live sessions capped at eight participants) for hands-on training in psychedelic-assisted therapy techniques.
  • KAT Immersive Experience Optional 3-day in-person experiential training where practitioners experience the full arc of ketamine-assisted therapy from the client perspective, including intake, preparation, supervised dosing weekend, and integration in groups of up to 10 participants.
  • CoCare Program Program enabling qualified therapists and practitioners to offer psychedelic-assisted therapy in their own practices with ATMA CENA providing clinical protocols, operational systems, and access to the clinic network.
  • National Clinic Network Member Program Franchise-like network partnership allowing clinic owners to integrate psychedelic-assisted therapy services with ATMA CENA providing regulatory guidance, staff training, clinical protocols, and exclusive market positioning per city.

Quantifiable outcome

  • Over 1,000 practitioners trained since 2021
  • +2 more outcomes

Companies that use ATMA CENA

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

ATMA CENA technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

ATMA CENA partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • MAPS CanadacoreStrategic or Co-development Partner · 1 October 2025Co-authored position paper on Alberta's Psychedelic Drug Treatment Services framework with MAPS Canada. Reverdi Darda, CEO, co-authored the report providing balanced analysis of provincial regulations. Joint advocacy for safety and access in psychedelic regulation.
  • The Rooted SpacecoreChannel Partner/ Reseller/ DistributorMember clinic partner in Kitchener-Waterloo, Ontario. Integrative wellness clinic offering psychedelic-assisted psychotherapy, traditional psychotherapy, neurofeedback, and holistic wellness services. Empowered by ATMA CENA to offer PAT services.
  • NeuroMedcoreChannel Partner/ Reseller/ DistributorMember clinic partner in Winnipeg providing psychedelic-assisted therapy services as part of ATMA CENA's national clinic network.
  • Evolve Counselling and WellnesscoreChannel Partner/ Reseller/ DistributorMember clinic partner in Saskatoon offering psychedelic-assisted therapy as part of the ATMA CENA national clinic network.
  • College of Physicians and Surgeons of Alberta (CPSA)coreStrategic or Co-development PartnerRegulatory oversight body that provides accreditation for ATMA CENA's Edmonton clinic and oversees the accreditation process for Calgary clinic. Sets standards for psychedelic-assisted therapy in Alberta under PDTS framework.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

ATMA CENA competitors and assessment

Company assessment

Direct peers

  • Braxia Scientific: Canadian ketamine clinic operator and psychiatric research platform (now part of Numinus). Directly comparable to ATMA CENA on ketamine-assisted therapy delivery and Canadian specialty outpatient mental-health positioning.
  • Field Trip Health: Was a leading Canadian psychedelic therapy clinic operator (ketamine-assisted psychotherapy) with locations across North America before ceasing operations. Served as the prior template for ATMA CENA's clinic-plus-network model in the Canadian market.
  • Numinus Wellness: Canadian psychedelic therapy company operating clinics and offering ketamine-assisted therapy alongside practitioner training. Numinus is the closest geographic and business-model peer to ATMA CENA, including its acquisition of Braxia Scientific (Canadian ketamine clinics).
  • Novamind: Operates specialty mental-health and ketamine-assisted therapy clinics in Canada alongside clinical research sites. Comparable to ATMA CENA in combining outpatient psychedelic therapy delivery with research capabilities.
  • Wesana Health: Focused on psychedelic-assisted therapies for traumatic brain injury and neurological conditions. Comparable niche overlap with ATMA CENA's chronic pain and tinnitus psychedelic treatment indications.

Emerging players

  • Cybin: Clinical-stage psychedelic therapeutics company developing psilocybin-based treatments for mental health. Comparable to ATMA CENA's psilocybin-assisted therapy segment but at the drug-development phase.
  • MAPS Public Benefit Corporation: Subsidiary of MAPS focused on developing and delivering MDMA-assisted therapy. Strongly comparable to ATMA CENA's MDMA-via-SAP offering and a key advocacy partner shaping psychedelic therapy policy that ATMA CENA is engaging.
  • GH Research: Clinical-stage company developing mebufotenin (5-MeO-DMT)-based therapies for treatment-resistant depression. Adjacent to ATMA CENA's psychedelic therapy menu, focused on a different molecule but a similar treatment-resistant mental-health patient population.

Broad incumbents

  • Compass Pathways: Public clinical-stage company developing psilocybin therapy for treatment-resistant depression. Overlaps with ATMA CENA on psilocybin-assisted therapy but operates as a drug-development incumbent rather than a clinic operator.
  • MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies. Comparable to ATMA CENA's PAT offering but at the biopharma development stage rather than clinic-delivery stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

ATMA CENA social profiles

Digital presence

ATMA CENA compliance and trust

Trust signal

Compliance4 records

ATMA CENA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ATMA CENA leadership team

Management profile

Number of profiles

Profiles9 records

ATMA CENA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ATMA CENA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATMA CENA

What does ATMA CENA do?

ATMA CENA operates a network of licensed clinics providing psychedelic-assisted therapy (using ketamine, psilocybin, and MDMA through the SAP), repetitive transcranial magnetic stimulation (rTMS), and general therapy services for treatment-resistant mental health conditions. The company complements its clinical practice with three CE/CME-accredited professional training pathways and a CoCare model that lets graduates deliver PAT within ATMA CENA-affiliated clinics, as well as a National Member Clinic Network that franchises ATMA CENA protocols and brand across Canada with one clinic per city.

Is ATMA CENA a public or private company?

ATMA CENA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ATMA CENA founded?

ATMA CENA was founded in 2023. It employs 11 to 50 people.

Where is ATMA CENA based?

ATMA CENA is headquartered in Calgary, Canada, in the North America region.

How does ATMA CENA make money?

Three revenue lines are on record. Clinical Therapy Services are the primary driver. The others are professional Training Programs and member Clinic Network.

Who are ATMA CENA's main competitors?

Direct peers on record are Braxia Scientific, Field Trip Health, Numinus Wellness, Novamind and Wesana Health. Emerging players are Cybin, MAPS Public Benefit Corporation and GH Research. Broad incumbents are Compass Pathways and MindMed.

Does ATMA CENA have an API?

No public API is recorded for ATMA CENA.

What industry is ATMA CENA in?

ATMA CENA's product category is Mental Healthcare / Psychedelic-Assisted Therapy Services. Its primary akta.pro industry code is EDAAALAD, Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE), with a secondary code of HLALAIAM, Controlled-Substance & High-Risk Medication Teleprescribing Platforms (compliance-focused). Its NAICS code is 621420 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireATMA CENA Grows National Mental Health Network to 13 ClinicsATMA CENA announced an expansion of its national clinic network to 13 locations, including new clinics in Windsor, Hamilton, North Bay, Montreal, and Saskatoon. The company's Member Clinic Program and CoCare training program support independent clinics and therapists. Nearly 1,000 students have completed its training programs.ForbesTranscendent Travel Set To Cross The 1 Trillion Mark In 2024Wellness tourism is projected to cross $1 trillion in 2024, with psilocybin retreats like MycoMeditations in Jamaica gaining traction. The Global Wellness Institute forecasts wellness trips rising to 8.3% of all tourism by 2027. Canada's ATMACENA offers supervised MDMA and psilocybin therapy under a Special Access Program.PR NewswireATMA Expands Practitioner In-Person Clinical Training to Bridge with Psychedelic-Assisted Therapy Clinical PracticeATMA Journey Centers Inc. announced the expansion of its psychedelic-assisted therapy training program with in-person clinical workshops on MDMA-assisted therapy using the MAPS protocol, scheduled for Calgary and London, Ontario in May-June 2024. The company is establishing the ATMA CENA clinic network with over a dozen planned sites to enable trained therapists to deliver PaT in Canada ahead of pending MDMA therapy legalization. ATMA CEO Vu Tran emphasized that bridging training and clinical practice addresses the anticipated shortage of qualified therapists as psychedelic therapies become legally available.YahooATMA CENA Psychedelic Healthcare Solutions Opens Psychedelic-Assisted Therapy Clinic in Calgary and Provides Update of its Clinic NetworkATMA CENA Psychedelic Healthcare Solutions opened its Calgary clinic and announced a new Edmonton location, with London and Toronto clinics starting in Q2 2024. The clinics will offer ketamine, rTMS, psilocybin, and MDMA-assisted therapy under Alberta's standards, and have received nine letters of intent from clinics.